By Justin Petrone

Two additional GenMark Diagnostics test panels may be available for clinical use in the US next year, CEO Hany Massarany said last week.

Massarany said that the Carlsbad, Calif.-based molecular-diagnostics firm is on track to submit its respiratory virus panel to the US Food and Drug Administration for 510(k) clearance before the end of the year. The panel allows users to test samples for the presence of 21 upper respiratory viruses.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.